The Food & Drug Administration cleared another Boston Scientific Corp. device, the second in as many days for the Natick device maker.
Hard on the heels of its nod to BSC’s Taxus Liberté Atom small-vessel coronary stent, the federal watchdog agency granted 510(k) approval to the SpyScope cholangioscopy catheter.
The device, previously approved only for bile and hepatic duct treatments, is used to guide visualization and accessory devices during procedures to diagnose and treat pancreatic cancer.